Morley Medical Sponsored Webinar: Rethinking “Early Catch” of Sepsis Using Game Changing Artificial Intelligence
Presented by Morley Medical
Early identification and detection of sepsis has been proven to reduce the prevalence of sepsis and sepsis related adverse clinical outcomes such as septic shock and death. In this webinar, learn how new advanced predictive analytics technology is revolutionizing how clinicians identify at risk patients by providing patient specific artificial intelligence driven clinical decision support.
This course was originally recorded on 7/22/2020.
Nurses, physician assistants, physicians, emergency responders, physical therapists, patient care assistants, and other healthcare staff
At the end of the presentation, the learner should be able to:
- Identify of other hospitalized acquired conditions can also streamline internal workflows utilizing artificial intelligence for conditions like CAUTI, CLABSI and VAP.
- Leverage artificial intelligence to understand the difference in patient acuity (ICU vs. other lower acuity units).
- Restate how to use feedback from artificial intelligence to create new standard of care options to treat sepsis in the attendee’s hospitals.
Sepsis Alliance gratefully acknowledges the support provided for this sponsor innovation webinar by Morley Medical.
CEO, Morley Medical, Inc.
Mr. Johnson has over two decades of experience in the healthcare industry as a CEO, investor, and board member for several medical device and software companies. He leads teams of seasoned clinical and regulatory affairs specialists, scientists, researchers and industry veterans. He started with American Medical Research Institute, Inc. (“AMRI”) which was an oncology site management organization that managed oncology clinical research projects for 120 Oncologists in multiple states in the United States. Some of those clients included Novartis, Pfizer, Eli Lilly, Merck and Amgen. This later turned into Morley Research Consortium (full service CRO) which has helped early to mid-stage companies achieve successful clinical trial results in over 24 disciplines. His current role is as CEO of Morley Medical, an innovator in artificial intelligence, machine learning and clinical data services.
Kiki Diorgu, MD, MBA
VP of Clinical Operations, Morley Medical, Inc.
Dr. Diorgu is a medical professional with outstanding experience in clinical research, business development, medical device and regulatory affairs. Dr. Diorgu serves as the Vice President of Clinical Operations for Morley Medical. In this role, Dr. Diorgu has provided scientific and operational leadership in overseeing various medical device and medical drug projects in therapeutic areas including but not limited to infectious diseases, general surgery, neurology, cardiology, orthopedics and oncology.
No continuing education credits are offered for this sponsored webinar.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
Thank you for registering for Rethinking “Early Catch” of Sepsis Using Game Changing Artificial Intelligence, sponsored by Morley Medical.
This activity includes:
- Downloadable slides
- Pre-recorded webinar
You can complete this activity at your convenience.